Heart Failure With Preserved Ejection Fraction trials recruiting in Illinois

All Heart Failure With Preserved Ejection Fraction trials nationally

Cities in Illinois

Recruiting trials in Illinois

• A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
  NCT07795814 · Phase: Phase 2 · Ages: 30 Years to 84 Years · Sex: All (male and female) · Illinois: Peoria
• HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets
  NCT05873634 · Phase: Not specified · Ages: 30 Years and older · Sex: All (male and female) · Illinois: Chicago
• Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
  NCT07037459 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Illinois: Hazel Crest
• Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction
  NCT06517186 · Phase: Not specified · Ages: 30 Years and older · Sex: All (male and female) · Illinois: Chicago
• Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction
  NCT02901184 · Phase: Phase 3 · Ages: 50 Years to 99 Years · Sex: All (male and female) · Illinois: Aurora, Chicago, Elk Grove Village, Peoria